In Vitro Evaluation and Pharmacokinetics in Dogs of Solid Dispersion Pellets Containing Silybum marianum Extract Prepared by Fluid-Bed Coating

Abstract

The solid dispersion of a poorly water-soluble Silybum marianum extract (SME) was prepared by a one-step fluid-bed coating technique depositing onto non-pareil pellets. In vitro evaluation indicated that this technique was highly efficient and reproducible producing pellets with acceptable appearance, flowability, friability, uniformity of drug content and enhanced dissolution. Physical characterization by DSC, powder X-ray diffractometry and FT-IR suggested the formation of a solid dispersion and possible interaction between PVP and the flavonolignans. Stress testing showed that the drug content and dissolution profiles of the SME solid dispersion pellets were sensitive to heat and humidity, while they are not affected under accelerated and long-term testing conditions. The relative bioavailability of solid dispersion pellets in dogs based on quantification of silibinin was about five-fold that of the SME suspension confirming enhanced oral bioavailability. It was concluded that the solid dispersion pellets prepared by fluid-bed coating showed favorable in vitro characteristics and enhanced oral bioavailability.

Key words

Silybum marianum - Asteraceae - milk thistle - flavonolignans - pharmacokinetics - solid dispersion - fluid bed - Silymarin

References

• 1 Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease.  Am J Gastroenterol. 1998;  93 139-43
• 2 Pepping J. Milk thistle: Silybum marianum. .  Am J Health Syst Pharm. 1999;  56 1195-7
• 3 Ding T M, Tian S J, Zhang Z X, Gu D Z, Chen Y F, Shi Y H. et al . Determination of active component in silymarin by RP-LC and LC/MS.  J Pharm Biomed Anal. 2001;  26 155-61
• 4 Kvasnicka F, Bíba B, Sevcík R, Voldrich M, Krátká J. Analysis of the active components of silymarin.  J Chromatogr A. 2003;  990 239-45
• 5 Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects.  Eur J Drug Metab Pharmacokinet. 1990;  15 333-8
• 6 Morazzoni P, Magistretti M J, Giachetti C, Zanolo G. Comparative bioavailability of silipide, a new flavanolignans complex in rats.  Eur J Drug Metab Pharmacokinet. 1992;  17 39-44
• 7 Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I. A comparation of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man.  Chem Pharm Bull. 1961;  9 866-72
• 8 Ford J L. The current status of solid dispersions.  Pharm Acta Helv. 1986;  61 69-88
• 9 Serajuddin A TM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.  J Pharm Sci. 1999;  88 1058-66
• 10 Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.  Int J Pharm. 2004;  272 1-10
• 11 Weuts I, Kempen D, Verreck G, Decorte A, Heymans K, Peeters J. et al . Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying.  Eur J Pharm Biopharm. 2005;  59 119-26
• 12 Sun N, Wei X, Wu B, Chen J, Lu Y, Wu W. Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique. Powder Tech 2007 doi: 10.1016/j.powtec.2007.05.029
• 13 Ho H O, Su H L, Tsai T, Sheu M T. The preparation and characterization of solid dispersions on pellets using a fluidized-bed system.  Int J Pharm. 1996;  139 223-9
• 14 Lu C, Lu Y, Chen J, Zhang W, Wu W. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system.  Eur J Pharm Biopharm. 2007;  66 210-9
• 15 Mascher H, Kikuta C, Weyhenmeyer R. Diastereomeric separation of free and conjugated silibinin in plasma by reversed phase HPLC after specific extraction.  J Liquid Chromatogr. 1993;  16 2777-89
• 16 Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.  Eur J Pharm Biopharm. 2006;  63 288-94
• 17 Karavas E, Ktistis G, Xenakis A, Georgarakis E. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone.  Eur J Pharm Biopharm. 2006;  63 103-14
• 18 Han Y H, Lou H X, Ren D M, Sun L R, Ma B, Jia M. Stereoselective metabolism of silybin diastereoisomers in the glucuronidation process.  J Pharm Biomed Anal. 2004;  34 1071-8
• 19 Emås M, Nyqvist H. Methods of studying aging and stabilization of spray-congealed solid dispersions with carnauba wax. 1. Microcalorimetric investigation.  Int J Pharm. 2000;  197 117-27
• 20 Urbanetz N A. Stabilization of solid dispersions of nimodipine and polyethylene glycol.  Eur J Pharm Sci. 2006;  28 67-76
• 21 Pillay V, Fassihi R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method.  J Control Release. 1998;  55 45-55
• 22 Polli J E, Rekhi G S, Augsburger L L, Shah V P. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets.  J Pharm Sci. 1997;  86 690-700
• 23 Livio S, Seghizzi R, Pifferi G. Diffusion behaviour of IdB 1016 across artificial and biological membranes. 4th European Congress of Biopharmaceutics and Pharmacokinetics. Geneva 1990: 17-9
• 24 Fillburn C R, Kettenacker R, Griffin D W. Bioavailability of a silybin-phosphatidylcholine complex in dogs.  J Vet Pharmacol Ther. 2007;  30 132-8
• 25 Woo J S, Kim T S, Park J H, Chi S C. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.  Arch Pharm Res. 2007;  30 82-9
• 26 Xiao Y Y, Song Y M, Chen Z P, Ping Q N. Preparation of silymarin proliposome: A new way to increase oral bioavailability of silymarin in beagle dogs.  Int J Pharm. 2006;  319 162-8